INTRODUCTION
Rhabdomyosarcoma (RMS) is the most common softtissue sarcoma of childhood, with an annual incidence of 4 to 7 per million children below 15 years of age. Approximately 65% of cases are diagnosed in children less than six years of age with remaining cases noted in the 10 to 18 year age group. 1 RMS is a highly malignant tumor and is thought to arise from primitive mesenchymal cells committed to develop into striated muscle. 2 In children and young adults, RMS tends to occur in the head and neck, extremities, and genitourinary tract. In contrast, ARMS rarely occurs in head and neck but commonly presents as truncal and extremity tumors. 3 Hence this case is being reported as it involved paranasal region, a rare site.
Overall more than 25% of patients have metastatic spread at the time of diagnosis, with the most common sites include lungs, lymph nodes, bone, and bone marrow. 4 The differential diagnosis of RMS includes 2 categories: the small round cell tumors of childhood and myogenic tumors of various types. 5 In their study, Tsung et al. have reported only 15% paediatric RMS presenting with metastasis in whereas more than 60% adult RMS have regional metastasis at diagnosis. 6 Herein, we discuss the cytological and histopathological features of small round cell tumors in children with reference to index case we encountered. A diagnosis of ARMS needs to be confirmed by ancillary techniques. The features were suggestive of small round cell tumor, probably PNET. Biopsy was advised for confirmation.
The biopsy tissue was soft, shiny brown fragment measuring 2.5x1.5x0.5 cm. Multiple sections including the deep part of specimen revealed a highly cellular pattern, composed of small round cells with thick and thin fibrous septa. The cells were clustered in the spaces surrounded by fibrous bands ( Figure 5 ). 
DISCUSSION
The cytological diagnosis for all small cell tumors is difficult unless the cytomorphology exhibits specific differentiation. The cytological diagnosis in this case was PNET as the tumor cells had small, round hyperchromatic nuclei, coarse chromatin, scant cytoplasm and occasional rosette formations. Alveolar RMS was ruled out due to absence of cells resembling rhabdomyoblast like eosinophilic cytoplasm and tumor giant cells.
RMS, a tumor derived from mesenchymal tissue, was first described by Weber in 1854. 3 Histomorphologically, pediatric RMS are classified as embryonal RMS (66% of cases), which is characterized by pronounced cellular pleomorphism, alveolar RMS (28%), undifferentiated RMS (4%) and anaplastic RMS (2%). In addition, embryonal RMS are subdivided into botryoid and spindle cell subtypes. 7 In this case, the tumor cells in ARMS were relatively small with scant cytoplasm. They had regular round nuclei with a monotonous chromatin pattern. The cells where in aggregates and were interrupted by fibrovascular septa. Within these aggregates, areas of discohesion were seen, resulting in spaces that resembled pulmonary alveoli. Similar features were described by Barr et al in a case report. 8 Tumors that appear alveolar under the microscope, but do not have an identifiable PAXFOXO1 translocation, should be classified as embryonal. 9 WHO defined rhabdomyosarcoma as a highly malignant tumor of rhabdomyoblasts in varying stages of differentiation with or without cross-striation. 10 Immunohistochemically, desmin, muscle specific actin and myogenin are considered to be of diagnostic value in RMS. 10 Our case showed strong immunopositivity with desmin.
The diagnosis of malignant small cell tumors is rather difficult as FNAC cannot differentiate between EWS, PNET and alveolar RMS. The cytological diagnosis of these tumors is usually based on clinical profile, cytology and routine microscopic examination. 11 In our case, the FNAC was very characteristic, which showed rosettes like structures with a few filaments inside these rosettes. The site, age and clinical presentation were indicating PNET/EWS. Alveolar RMS was considered even though tumor giant cells and eosinophilic cytoplasm were absent. A number of studies have addressed the issue of diagnosis of EWS/ PNET by FNAC based on immunohistochemistry. 12 Few authors have recommended that ancillary facilities may not be available in developing countries, hence tissue diagnosis may be offered often based on cytomorphological features of FNAC, as a life saving measures in seriously ill patients. 13 In the indexed case, though FNAC revealed PNET, the authors proceeded with tissue biopsy.
Microscopically, EWS/PNET is composed of uniform small round cells with round nuclei containing fine chromatin, scanty, clear or eosinophilic cytoplasm and indistinct cytoplasmic membranes. The term PNET has been used for tumors that demonstrate neuroectodermal features. PNET shows more frequent nucleoli, mitotic activity as well as necrosis and Homer-Wright rosettes. EWS/PNET is characterized by immunoreactivity for the surface antigen CD99/MIC2, which is expressed in up to 97% of cases.
14 The term Ewing's sarcoma is used for tumors which do not exhibit neuroectodermal differentiation. Use of myogenic markers, particularly myogenin, may be helpful in identifying few cases of EWS/PNET, noting that desmin positivity may occur in rare peripheral neuroectodermal tumors. CD99, often used as a Ewing's tumour marker, may be positive in RMS. 5 Some recent studies suggest that for diagnosing alveolar RMS, morphology should be coupled with fusion confirmation. All tumors that have histologic evidence of alveolar features (cytologically and/or architecturally) should be always evaluated with FISH technique. Astekar M et al. (2012) have found that hamotoxylin and eosin morphology and ultra-structure are needed to classify RMS, whereas immunohistochemistry acts only as auxiliary investigation. 
